Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Quanticate makes investment ahead of the upcoming Article 2(3) of Directive 2010/84/EU
July 14, 2017
By: Tim Wright
Editor-in-Chief, Contract Pharma
Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform in preparation for the upcoming Article 2(3) of Directive 2010/84/EU that will impact the pharmaceutical industry later this year. The data-focused clinical research organization (CRO) has made the move following the European Medicines Agency’s (EMA) planned launch of an improved version of EudraVigilance, the European information system for suspected adverse events to medicines in the European Economic Area, on November 22, 2017. The new system will simplify adverse event reporting in the EU and enhance data availability to stakeholders for improved signal detection activities. The capability expansion enables Quanticate to offer pharmaceutical clients direct and immediate access to a fully compliant safety database without them needing to invest in their own system or use an interim solution to ensure compliance. “As clinical data experts, we always aim to be at the forefront of compliance, hence our proactive onboarding of the upcoming E2B(R3) requirements and our technology investment,” said Tom Nichols, senior director pharmacovigilance, Quanticate. “It is up to sponsors, marketing authorization holders and clinical research organizations to make the transition and we believe our pre-emptive upgrade avoids the need for pharmaceutical organizations to use cumbersome and short-term conversion tools, which simply delay the inevitable need to upgrade later to become fully compliant. Now that our enhanced database is up and running, we can provide this solution to drug developers straightaway using our web-based hosting platform before the regulations become fully mandatory.” Quanticate’s decision to update to the latest version of Argus v8,1 has been taken to reinforce the niche CRO’s position beyond typical pharmacovigilance service offerings as the company also supports small to large sized pharmaceutical companies with pharmacovigilance safety database hosting technology as a service.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !